The Island/CannabisMarket Dynamic
Hawaii’s cannabis market operates under conditions unlike any mainland state, and those conditions shape every aspect of the industry’s economics.
Limited Dispensary Access
The medical program operates through a closed licensing system — the state issued a fixed number of licenses and hasn’t opened applications for new entrants. Eight dispensary licenses were issued under the 2015 Medical Cannabis Dispensary Program, with each licensee permitted to operate up to two retail locations.
Currently, 25 dispensary locations serve the entire state across four islands: Oahu, Maui, Hawaii Island, and Kauai. Molokai and Lanai have no dispensaries. Patients on those islands report average travel times of 70 and 90 minutes to reach the nearest retail location.
Every transaction in this market occurs under a legal contradiction that shapes its structure. Cannabis remains a Schedule I substance under the federal Controlled Substances Act; possession, manufacture, and distribution are federal felonies regardless of state authorization. Hawaii’s dispensaries operate legally under state law while technically violating federal law with every sale. That tension is not abstract: it restricts access to banking services, deters institutional investment, and means the CPPC report’s billion-dollar projections carry an embedded legal risk that no state-level policy can resolve on its own.
Geographic Isolation Affects Supply
Geographic isolation shapes the market in ways not seen on the mainland. Located about 2,500 miles from the continental United States, Hawaii’s cannabis operators can’t simply drive to the nearest supplier when equipment fails or inventory runs low.
This isolation changes how operators buy: they invest in reliable equipment and long-term partnerships because the cost of replacing gear or sourcing emergency supplies from the mainland is far higher than for operators with access to regional distribution networks.
The islands’ tropical climate adds another layer. Persistent humidity means growing operations must actively remove moisture from the air — a step that is optional on the mainland but essential in Hawaii. The CPPC report notes that indoor growing requires careful management of humidification, and pest pressure and mold risks exceed mainland conditions. These factors drive demand for specialized climate control systems, pest management approaches that combine biological and cultural strategies, and genetics selected for tropical growing conditions.
Tourism: The Market Multiplier No Other State Has
Hawaii’s most distinctive market trait is its integration with one of the world’s most valuable tourism economies. The state welcomed about 9.7 million visitors in 2024 who spent roughly $20.7 billion, according to the
Hawaii Department of Business, Economic Development and Tourism. The CPPC report made this tourism economy a central focus, and the findings directly address the political objection that has most consistently blocked legalization.
US Tourists
Researchers surveyed tourists from the United States, Canada, and Japan about their cannabis spending patterns and willingness to buy in a legal market. Domestic U.S. tourists indicated an average willingness to spend $124.65 per trip on cannabis products. This is a self-reported survey figure reflecting what respondents expected to spend, not a measure of actual purchases — but at scale it points to major potential cannabis tourism revenue.
Japanese Tourists
The survey data from international markets was, for legalization advocates, arguably more important than the domestic numbers. Japanese tourists represent Hawaii’s largest international visitor market, and concern about negative reactions from Japanese visitors has been a persistent argument against legalization in the Hawaii legislature. The CPPC data undercuts that argument directly. About 57.5% of Japanese respondents said adult-use legalization would have no influence on their decision to visit Hawaii.
Canadian Tourists
Canadian respondents showed even more favorable results. Among the full Canadian survey sample, 64.5% reported no influence on their travel decisions. Given that Canada legalized cannabis federally in 2018, Canadian tourists are already familiar with regulated markets.
The report also examined a natural experiment in Guam, a U.S. territory in the Pacific that legalized adult-use cannabis in April 2019. Researchers tested whether legalization caused a measurable shift in Guam’s tourism trends and found no significant link to either an increase or a decrease in tourism from Japan or South Korea. For Hawaii, where the tourism deterrence argument has been the most powerful political objection to legalization, this finding matters.
The CPPC report projects that tourism would add at least $11.5 million monthly to Hawaii’s cannabis market — a constant baseline that would vary with seasonal visitor patterns. This tourism multiplier sets Hawaii apart from every mainland market and creates year-round demand stability that few other states can match.
The Billion-Dollar Projection for Hawaii’s Cannabis Market
Using growth data from 11 states with existing adult-use markets, the CPPC report models Hawaii’s cannabis market under two scenarios. The first does not account for how taxes would affect buying behavior. The second adjusts for consumer response to a 15% total tax rate.
Under the tax-adjusted scenario — which the report treats as more realistic — the total cannabis market could reach $46 to $90 million monthly by year five of adult-use sales. Without the tax adjustment, those figures rise to $59 to $95 million monthly. The report doesn’t estimate tax revenue directly, noting that “any external application of a flat tax rate to these projections should be interpreted with caution”.
Meeting that demand would require major infrastructure growth. The report estimates Hawaii would need about 65 retail dispensaries statewide in the first year to serve adult-use consumers, medical patients, and tourists — more than double the current 25. Growing facilities would need to expand to between 17 and 67 indoor operations, or between 47 and 376 outdoor facilities, depending on how much growing space regulators permit per license. Total production needs would average about 117,500 plants harvested and cured — dried and processed for sale — per year, roughly 9,700 per month.
For context, the current medical program serves about 29,800 patients. An adult-use market would need to serve an estimated 110,456 adult consumers plus tourists — roughly a four-fold increase in production capacity.
